Pharma Archives - Page 2 of 68 - Life Sciences Times

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

THIS WEEK'S STORIES

Point32Health Appoints Patrick Gilligan as CEO, Effective June 16

June 2, 2025

HAYA Therapeutics Relocates to Lilly Gateway Labs to Accelerate RNA-Guided Therapeutics Development

June 3, 2025

Tempus Launches ‘Fuses’ to Build AI-Driven Diagnostic Platform and Advance Therapeutic Research

May 31, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Acerand Therapeutics Begins First-in-Human Trial of ACE-232 for Advanced Prostate Cancer

Seyltx Reports Promising Preclinical Results for Chronic Cough Drug Ifenprodil Ahead of Phase 2 Trials

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Most Read

Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy

Suffolk Unveils White Paper to Drive Climate Tech Adoption in Construction Industry

Tracer Biotechnologies Partners with QIAGEN to Expand Blood-Based Cancer Testing

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

EDITOR PICKS

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

THIS WEEK'S STORIES

Point32Health Appoints Patrick Gilligan as CEO, Effective June 16

HAYA Therapeutics Relocates to Lilly Gateway Labs to Accelerate RNA-Guided Therapeutics Development

Tempus Launches ‘Fuses’ to Build AI-Driven Diagnostic Platform and Advance Therapeutic Research

POPULAR CATEGORY

ABOUT US

FOLLOW US